164 related articles for article (PubMed ID: 33298775)
21. The Value of IOTA Simple Rules Combined With CEUS Scoring System in the Diagnosis of Benign and Malignant Ovarian Masses and Its Correlation With MVD and VEGF: A Preliminary Study.
Liu C; Li Y; Zhu Y; Lu M
J Ultrasound Med; 2022 Dec; 41(12):2983-2992. PubMed ID: 35481545
[TBL] [Abstract][Full Text] [Related]
22. Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound.
Wang Y; Fan W; Zhao S; Zhang K; Zhang L; Zhang P; Ma R
Eur J Radiol; 2016 Jan; 85(1):48-54. PubMed ID: 26724648
[TBL] [Abstract][Full Text] [Related]
23. Study on the characteristics of contrast-enhanced ultrasound and its utility in assessing the microvessel density in ovarian tumors or tumor-like lesions.
Wang J; Lv F; Fei X; Cui Q; Wang L; Gao X; Yuan Z; Lin Q; Lv Y; Liu A
Int J Biol Sci; 2011; 7(5):600-6. PubMed ID: 21614152
[TBL] [Abstract][Full Text] [Related]
24. Gynecology Imaging Reporting and Data System (GI-RADS): diagnostic performance and inter-reviewer agreement.
Basha MAA; Refaat R; Ibrahim SA; Madkour NM; Awad AM; Mohamed EM; El Sammak AA; Zaitoun MMA; Dawoud HA; Khamis MEM; Mohamed HAE; El-Maghraby AM; Abdalla AAEM; Assy MM; Nada MG; Obaya AA; Abdelbary EH
Eur Radiol; 2019 Nov; 29(11):5981-5990. PubMed ID: 30993433
[TBL] [Abstract][Full Text] [Related]
25. The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study.
Testa AC; Timmerman D; Exacoustos C; Fruscella E; Van Holsbeke C; Bokor D; Arduini D; Scambia G; Ferrandina G
Ultrasound Obstet Gynecol; 2007 May; 29(5):512-6. PubMed ID: 17444549
[TBL] [Abstract][Full Text] [Related]
26. O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses.
Shi Y; Li H; Wu X; Li X; Yang M
J Ovarian Res; 2023 Aug; 16(1):153. PubMed ID: 37537697
[TBL] [Abstract][Full Text] [Related]
27. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
[TBL] [Abstract][Full Text] [Related]
28. Value of contrast-enhanced ultrasound in the diagnosis of breast US-BI-RADS 3 and 4 lesions with calcifications.
Cheng M; Tong W; Luo J; Li M; Liang J; Pan F; Pan J; Zheng Y; Xie X
Clin Radiol; 2020 Dec; 75(12):934-941. PubMed ID: 32814625
[TBL] [Abstract][Full Text] [Related]
29. Contrast-Enhanced Ultrasonography versus Contrast-Enhanced Magnetic Resonance Imaging in the Diagnosis of Mediastinal Tumors.
Pan J; Chen W; Zhang H; Huang X; Huang X
Ultrasound Med Biol; 2021 Feb; 47(2):261-271. PubMed ID: 33153806
[TBL] [Abstract][Full Text] [Related]
30. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
[TBL] [Abstract][Full Text] [Related]
31. Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?
Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Habermann C; Wessling J
Ultraschall Med; 2011 Dec; 32(6):582-92. PubMed ID: 22161555
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of thyroid imaging reporting and data system (TI-RADS) alone and in combination with contrast-enhanced ultrasonography for the characterization of thyroid nodules.
Zhao H; Liu X; Lei B; Cheng P; Li J; Wu Y; Ma Z; Wei F; Su H
Clin Hemorheol Microcirc; 2019; 72(1):95-106. PubMed ID: 30320563
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20 mm) and subcentimetric (≤ 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.
Strobel D; Bernatik T; Blank W; Schuler A; Greis C; Dietrich CF; Seitz K
Ultraschall Med; 2011 Dec; 32(6):593-7. PubMed ID: 22161556
[TBL] [Abstract][Full Text] [Related]
34. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
[TBL] [Abstract][Full Text] [Related]
35. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.
Seitz K; Strobel D
Ultraschall Med; 2016 Jun; 37(3):229-32. PubMed ID: 27276056
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study.
Ooi CC; Low SC; Schneider-Kolsky M; Lombardo P; Lim SY; Abu Bakar R; Lo RH
J Med Imaging Radiat Oncol; 2010 Oct; 54(5):421-30. PubMed ID: 20958940
[TBL] [Abstract][Full Text] [Related]
37. Two- and three-dimensional contrast-enhanced sonography for assessment of renal tumor vasculature: preliminary observations.
Wei S; Fu N; Yao C; Liu P; Yang B
J Ultrasound Med; 2013 Mar; 32(3):429-37. PubMed ID: 23443183
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Contrast-Enhanced Ultrasound versus Contrast-Enhanced Magnetic Resonance Imaging for the Diagnosis of Focal Liver Lesions Using the Liver Imaging Reporting and Data System.
Wang JY; Feng SY; Yi AJ; Zhu D; Xu JW; Li J; Cui XW; Dietrich CF
Ultrasound Med Biol; 2020 May; 46(5):1216-1223. PubMed ID: 32115307
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
[TBL] [Abstract][Full Text] [Related]
40. Additional value of contrast-enhanced ultrasound (CEUS) on arterial phase non-hyperenhancement observations (≥ 2 cm) of CT/MRI for high-risk patients: focusing on the CT/MRI LI-RADS categories LR-3 and LR-4.
Kang HJ; Kim JH; Joo I; Han JK
Abdom Radiol (NY); 2020 Jan; 45(1):55-63. PubMed ID: 31332503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
